David P. Berry

Consumption of the Putative Chemopreventive Agent Curcumin by Cancer Patients: Assessment of Curcumin Levels in the Colorectum and their Pharmacodynamic Consequences

Giuseppe Garcea, David P. Berry, Donald J. L. Jones et al. · Cancer Epidemiology Biomarkers & Prevention · 2005 · 484 citations · Full text

Chemoprevention Strategy, Pathology, Pharmacotherapy +16

Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration

Giuseppe Garcea, Donald J. L. Jones, Rajinder Singh et al. · British Journal of Cancer · 2004 · 421 citations · Full text

Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy

Mark I. James, Chinenye Iwuji, Glen R.B. Irving et al. · Cancer Letters · 2015 · 179 citations · Full text

Chemoprevention Strategy, Medicine, Cancer Stem Cell +13

Prolonged Biologically Active Colonic Tissue Levels of Curcumin Achieved After Oral Administration—A Clinical Pilot Study Including Assessment of Patient Acceptability

Glen R.B. Irving, Lynne Howells, Stewart Sale et al. · Cancer Prevention Research · 2012 · 109 citations · Full text

Curcumin ameliorates oxaliplatin‐induced chemoresistance in HCT116 colorectal cancer cells <i>in vitro</i> and <i>in vivo</i>

Lynne Howells, Stewart Sale, Sathya Neelature Sriramareddy et al. · International Journal of Cancer · 2010 · 96 citations · Full text

Tumor Biology, Oncology, Chemoprevention Strategy +14